Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Real-World Evidence: Observational Studies Deserve More Respect In US FDA Framework
Apr 30 2019
•
By
Sue Sutter
Industry wants an open door for use of observational studies to support efficacy claims. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approval Standards
More from Pathways & Standards